1 terminated, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 1, Unknown 1 |
Follow Poniard Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Picoplatin Efficacy After Relapse picoplatin, best supportive care - Small Cell Lung Cancer | Phase 3 | Unknown | Poniard Pharmaceuticals | 399 | 2007-04-01 | 2009-04-14 |
| Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma STR(TM) (Skeletal Targeted Radiotherapy, Holmium-166-DOTMP) - Multiple Myeloma | Phase 3 | Terminated | Poniard Pharmaceuticals | 240 | 2004-03-01 | 2009-03-31 |
Multiple Myeloma (1) · Small Cell Lung Carcinoma (1)
amminedichloro(2-methylpyridine)platinum(II) (1) · holmium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid) (1)
Argentina (1) · Belarus (1) · Bosnia and Herzegovina (1) · Bulgaria (1) · Canada (1) · Chile (1) · Croatia (1) · Hungary (1) · India (1) · Latvia (1) · Montenegro (1) · Poland (1) · Romania (1) · Russia (1) · Serbia (1)